Skip to main content
Top

Chinese Journal of Cancer Research

Issue 2/2009

Content (13 Articles)

Cellular and Molecular Biology

FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells

Wei-dong Han, Zhi-qiang Wu, Ya-li Zhao, Yi-ling Si, Xiao-bing Fu

Gynecologic Cancer

Human papillomavirus 16E6 oncogene mutation in cervical cancer

Feng Sun, Xiao-qin Ha, Tong-de Lv, Chuan-ping Xing, Bin Liu, Xiao-zhe Cao

Breast Cancer

Long-term efficacy and safety of pamidronate disodium in treatment of bone metastases in breast cancer

Li-jun Di, Jun Ren, Ying Yan, Feng-ling Wan, Guo-gong Song, Jing Yu

Gastrointestinal Cancer

Relationship between VEGF, EGF and invasion, metastasis of gastric cancer cells

Chun-feng Li, Yan Ma, Yu-zhe Wei, Ying-wei Xue

Expression of obesity hormone leptin in human colorectal cancer

Jin-chun Cong, Xian-wei Dai, Ming-yang Shen, Jun-jiang Wang, Chun-sheng Chen, Hong Zhang, Lei Qiao

Anticancer Pharmacology

Potential anti-cancer activity of furanodiene

Zhen-zhen Ba, Yan-ping Zheng, Hui Zhang, Xiu-yan Sun, Dong-hai Lin

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine